Please login to the form below

Not currently logged in
Email:
Password:

EMA geriatric expert group

The European Medicines Agency has established an expert group to provide advice on issues related to the elderly as part of the agency's Committee for Medicinal Products for Human Use

The European Medicines Agency (EMA) has established an expert group to provide advice on issues related to the elderly as part of the agency's Committee for Medicinal Products for Human Use (CHMP).

The geriatric group consists of nine experts in the field who will assist the CHMP in several ways, including giving input on guidelines under consultation and adding a geriatric viewpoint on discussions concerning the development, assessment or safety monitoring of medicines.

Members will meet on an ad-hoc basis, communicating by e-mail, telephone conference or web conference rather than in person.

The creation of the group is part of the EMA's geriatric medicines strategy (PDF), published in February 2011.

The strategy was developed to take into account the changing environment of modern healthcare, with an increasingly ageing population.

The implementation of the strategy was described in the EMA's 'road map' to 2015, which identifies three priority areas for the agency to focus on: addressing needs in public health; facilitating access to medicines; and making sure use of medicines is safe.

8th June 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics